openPR Logo
Press release

Atherosclerotic Renovascular Treatment Market Comprehensive Analysis of World Markets & Trade, 2028

02-06-2019 07:29 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Fact.MR

Atherosclerotic Renovascular Treatment Market Comprehensive

Atherosclerotic renovascular disease refers to the stenosis of either one or both renal arteries. The stenosis occurs due to the accumulation of fat or calcium deposits on the walls of the artery. Atherosclerotic renovascular disease is a rare disorder and its exact epidemiology is not available. Although the prevalence of atherosclerotic renovascular disease is not known, the dialysis registry data provides some hint of patients with atherosclerotic renovascular disease. In a study conducted on cardiovascular health in the U.S. about 6.8% of healthy candidates over the age of 65 years are found to have clinically silent atherosclerotic renovascular disease. Atherosclerotic renovascular disease is increasingly gaining recognition and importance. This is due to the condition of patients as they tend to go for dialysis, which reflects their systemic atherosclerotic burden. In an effort to delay and perhaps prevent their need for renal replacement therapy, some patients are subjected to a variety of medical, radiological and surgical interventions. The management of atherosclerotic renovascular disease is controversial. Some evidence suggests that treatment with renal stent may be beneficial, however, clinical trials have failed to demonstrate significant benefits.

Over the past 80 years there has been a significant change in the understanding of atherosclerotic renovascular treatment. Currently, the atherosclerotic renovascular treatment consists of medical therapy, angioplasty, renal artery stenting and surgery. Patients who show mild to medium symptoms can benefit with the use of atherosclerotic renovascular treatment by medical therapy. This mode of atherosclerotic renovascular treatment generally includes the use of drugs particularly anti-hypertension drugs, exercise and regular check-ups. Angioplasty for atherosclerotic renovascular treatment is also beneficial in case of patients who have significant narrowing of the renal artery. However, in case the angioplasty atherosclerotic renovascular treatment is not sufficient or if it is an ineffective atherosclerotic renovascular treatment, renal artery stenting can be performed to ensure the dilated artery maintains its structure.

Atherosclerotic renovascular treatment by surgery is recommended to patients with severely high blood pressure or renal failure. The surgical atherosclerotic renovascular treatment is of two types. The first type is a renal artery endarterectomy, the plaque in the renal artery is removed through an incision through the abdomen. Another form of atherosclerotic renovascular treatment by surgery is that of renal artery bypass. In this type of surgery the defected or plaque section of the renal artery is removed and replaced with a healthy vein from another part of the body. Patients undergoing atherosclerotic renovascular treatment by surgery need to be in the hospital for about a week.

Click here to subscribe Sample @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2035 

Atherosclerotic Renovascular Treatment Market: Drivers and Restraints

Increase in ageing population and with the increase in prevalence of various conditions such as cardiovascular conditions, diabetes, smoking and hypertension drive the growth of the atherosclerotic renovascular treatment market. However, other factors such as high rate of unsuccessful renal revascularization as an atherosclerotic renovascular treatment may hinder the growth of the atherosclerotic renovascular treatment market.

Atherosclerotic Renovascular Treatment Market: Segmentation

Tentatively, the global atherosclerotic renovascular treatment market can be segmented on the basis of product type, treatment type, end users, and geography.

Based on product type, the global atherosclerotic renovascular treatment market is segmented as:

Hypertension drugs
Stents
Angioplasty devices
Based on treatment type, the global atherosclerotic renovascular treatment market is segmented as:

Medical Treatment
Angioplasty
Renal artery stenting
Surgery
Based on end users, the global atherosclerotic renovascular treatment market is segmented as:

Hospitals
Specialty Clinics
Ambulatory Centers
Atherosclerotic Renovascular Treatment Market: Overview

The global atherosclerotic renovascular treatment is expected to witness moderate growth over the forecast period. The atherosclerotic renovascular treatments can be broadly classified based on the treatment as medical treatment, angioplasty, renal artery stenting and surgery. The atherosclerotic renovascular treatment by renal revascularization methods such as angioplasty and renal artery stenting have tough competition from players that offer hypertension drug products used for atherosclerotic renovascular treatments.

Request/View TOC@ https://www.factmr.com/connectus/sample?flag=T&rep_id=2035 

Atherosclerotic Renovascular Treatment Market: Regional Outlook

Geographically, the global atherosclerotic renovascular treatment market is segmented into North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America is expected to be the dominant market in the global atherosclerotic renovascular treatment market owing to technology advancements, awareness of general public, increasing healthcare spending and substantial reimbursement. The atherosclerotic renovascular treatment market in Asia Pacific excluding Japan is expected to grow at a significant CAGR due to increased R&D spending and advancements in technology.

Atherosclerotic Renovascular Treatment Market: Key Players

The global market for atherosclerotic renovascular treatment is highly fragmented. Examples of some of the key players operating in the global atherosclerotic renovascular treatment market are Boston Scientific, Abbott, Cook Medical, Medtronic PLC, and Cordis Corporation, among others.

This analytical research study imparts an all-inclusive assessment on the market, while propounding historical intelligence, actionable insights, and industry-validated & statistically-upheld market forecast. Verified and suitable set of assumptions and methodology has been leveraged for developing this comprehensive study. Information and analysis on key market segments incorporated in the report has been delivered in weighted chapters. A thorough analysis has been offered by the report on

Market Dynamics
Market Size
Market Segments
Demand & Supply Trends
Current Issues and Challenges
Companies and Competitor Landscape
Value Chain
Technology
Regional Segments Analyzed Include

North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain)
Eastern Europe (Poland, Russia)
Asia Pacific (China, India, ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC, S. Africa, N. Africa)
Compilation of authentic and first-hand intelligence, insights offered in the report are based on quantitative and qualitative assessment by leading industry experts, and inputs from opinion leaders & industry participants around the value chain. Growth determinants, macroeconomic indicators, and parent market trends have been scrutinized and delivered, coupled with the market attractiveness for each market segment encompassed. Qualitative impact of growth influencers on the market segments across regions has also been mapped by the report.

Highlights from the Report

Elaborated scenario of the parent market
Transformations in the market dynamics
Detailed segmentation of the target market
Historical, current and forecast market size based on value and volume
Latest industry developments and trends
Competition landscape
Strategies adopted by the market players and product developments made
Potential and niche segments, along with their regional analysis
Unbiased analysis on performance of the market
Up-to-date and must-have intelligence for the market players to enhance and sustain their competitiveness

Grow Your Business From Expert Advice: https://www.factmr.com/report/2035/atherosclerotic-renovascular-treatment-market 

About US
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Rohit Bhisey
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/
Read Industry News at - http://theguardiantribune.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Atherosclerotic Renovascular Treatment Market Comprehensive Analysis of World Markets & Trade, 2028 here

News-ID: 1563472 • Views:

More Releases from Fact.MR

Healthcare AR VR Market Dynamics: Influence of Key Players Including Atheer, Augmedix, and Vuzix Corporations
Healthcare AR VR Market Dynamics: Influence of Key Players Including Atheer, Aug …
The global healthcare AR VR market is experiencing explosive growth, with its valuation expected to surge from USD 2.8 billion in 2024 to USD 14.85 billion by 2034. This remarkable expansion reflects a compound annual growth rate (CAGR) of 18.2% over the forecast period from 2024 to 2034. The market's momentum is driven by the transformative potential of augmented reality (AR) and virtual reality (VR) in enhancing medical training, surgical
Ad-Supported Video on Demand (AVOD) Market to Reach USD 47.84 Billion by 2034, Led by Key Players like Tubi, Pluto TV, Roku, IMDb TV, and Freevee
Ad-Supported Video on Demand (AVOD) Market to Reach USD 47.84 Billion by 2034, L …
In an era where binge-watching has become a global pastime, the ad-supported video on demand (AVOD) market is poised for unprecedented expansion, according to a groundbreaking new report from Fact.MR. Valued at US$ 40.12 billion in 2024, the sector is projected to skyrocket to US$ 150.8 billion by 2034, achieving a robust compound annual growth rate (CAGR) of 14.2%. This meteoric rise underscores the transformative power of AVOD platforms, which
Continuous Positive Airway Pressure (CPAP) Device Market Expanding at 5.45% CAGR, Driven by Key Players: ResMed, Philips, Fisher & Paykel, Invacare, and DeVilbiss Healthcare
09-23-2025 | Health & Medicine
Fact.MR
Continuous Positive Airway Pressure (CPAP) Device Market Expanding at 5.45% CAGR …
The global continuous positive airway pressure (CPAP) device market is on a steady growth trajectory, with its valuation expected to rise from USD 3,969.5 million in 2024 to USD 7,286.3 million by 2034. This expansion corresponds to a compound annual growth rate (CAGR) of 6.3% over the forecast period from 2024 to 2034. The market's momentum is driven by the increasing prevalence of sleep apnea, growing awareness of sleep disorders,
Cranio Maxillofacial Fixation Device Market is Projected to Reach USD 6,030 Million by 2035 | DePuy Synthes; KLS Martin Group; Xilloc Medical B. V; Synimed; Zimmer-Biomet; Stryker
09-23-2025 | Health & Medicine
Fact.MR
Cranio Maxillofacial Fixation Device Market is Projected to Reach USD 6,030 Mill …
The global cranio maxillofacial fixation device market is expected to experience significant growth, with its valuation rising from USD 2,946 million in 2025 to USD 6,030 million by 2035. This expansion corresponds to a compound annual growth rate (CAGR) of 7.4% over the forecast period from 2025 to 2035. The market's momentum is driven by rising concerns over facial trauma and genetic imperfections, increasing demand for minimally invasive surgeries, and

All 5 Releases


More Releases for Atherosclerotic

Atherosclerotic Cardiovascular Disease Market to Witness Growth by 2032, Estimat …
DelveInsight's "Atherosclerotic Cardiovascular Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Atherosclerotic Cardiovascular Disease, historical and forecasted epidemiology as well as the Atherosclerotic Cardiovascular Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Atherosclerotic Cardiovascular Disease market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted
ICAD (Intracranial Atherosclerotic Disease) Pathology Market 2021 | Detailed Rep …
ReportsnReports publishes the report titled ICAD (Intracranial Atherosclerotic Disease) Pathology that presents a 360-degree overview of the market under one roof. The report is developed with the meticulous efforts of an enthusiastic and experienced team of experts, analyts, and researchers that makes the report a valuable asset for stakeholders to make robust decisions. This report also provides an in-depth overview of product type, specification, technology, and production analysis considering vital
Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Insights and …
The increasing constriction of the cerebral arteries within the skull is known as intracranial atherosclerotic disease (intracranial). The carotid arteries and the vertebral arteries are the arteries that give oxygen-rich blood to the brain. The area at the base of the brain known as the Willis circle connects these arteries. Get sample copy of this report @ https://www.infinitybusinessinsights.com/request_sample.php?id=458201 Increasing demand for cutting
ICAD (Intracranial Atherosclerotic Disease) Pathology Market 2020 Latest Researc …
Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery The report will make detailed analysis mainly on in-depth research on the development environment, Market size, development trend, operation situation and future development trend of ICAD (Intracranial Atherosclerotic Disease) Pathology Market on the basis of stating current situation of the industry in 2020. This is a latest report, covering the current COVID-19
Intracranial Atherosclerotic Disease Treatment Market Size, Share, Development b …
LP INFORMATION recently released a research report on the Intracranial Atherosclerotic Disease Treatment market analysis, which studies the Intracranial Atherosclerotic Disease Treatment's industry coverage, current market competitive status, and market outlook and forecast by 2025. Global “Intracranial Atherosclerotic Disease Treatment Market 2020-2025” Research Report categorizes the global Intracranial Atherosclerotic Disease Treatment market by key players, product type, applications and regions,etc. The report also covers the latest
Atherosclerotic Renovascular Treatment Market Soaring Demand Assures Motivated R …
Atherosclerotic renovascular disease refers to the stenosis of either one or both renal arteries. The stenosis occurs due to the accumulation of fat or calcium deposits on the walls of the artery. Atherosclerotic renovascular disease is a rare disorder and its exact epidemiology is not available. Although the prevalence of atherosclerotic renovascular disease is not known, the dialysis registry data provides some hint of patients with atherosclerotic renovascular disease. In